Caricamento quotazioni...
Previsioni
Non sono disponibili dati degli analisti per questa azienda.
Notizie Vai al feed delle notizie
DocCheck reports preliminary 2025 results: revenue and EBIT rise
DocCheck expects 2025 revenue of between €55.1 million and €55.4 million (previous year: €53.8 million) and EBIT of €7.8 million to €8.1 million (previous year: €6.6 million), putting EBIT above the most recently adjusted forecast. The cause is a better-than-expected business performance in the fourth quarter of 2025. Cash and cash equivalents fell to €14.5 million (previous year: €17.0 million); earnings per share cannot yet be quantified. For 2026 the company expects organic growth in an economically challenging environment. » Altro su finanzen.net
DocCheck reports preliminary nine-month figures: revenue and EBIT increased
The DocCheck Group generated revenue of €39.7 million in the first nine months of 2025 (previous year: €37.5 million) and an EBIT of €5.5–5.8 million (previous year: €3.5 million). The revenue forecast for 2025 remains €50.0–55.0 million, while the earnings forecast was raised from €5.0–5.5 million to €6.5–6.8 million. Liquid funds amounted to €14.9 million at the reporting date (previous year: €15.8 million); statements on earnings per share are not yet possible. » Altro su finanzen.net
Dividendi storici Dividendi
Tutte le metriche sui dividendi Tutte le metricheDati finanziari dell'azienda
| (EUR) | dic 2025 | |
|---|---|---|
| Ricavi | 28,77M | - |
| Utile lordo | 6,39M | - |
| Utile netto | 2,88M | - |
| EBITDA | 5,90M | - |
Dati fondamentali
| Metrica | Valore |
|---|---|
Capitalizzazione di mercato | 55,30M€ |
Numero di azioni | 5,07M |
Massimo/minimo a 52 settimane | 15,90€ - 10,60€ |
Rendimento da dividendo | 9,26% |
Dividendi TTM | 1,00€ |
Beta | 0,9 |
Rapporto P/E | 10,38 |
Rapporto PEG | 10,80 |
Rapporto P/B | 1,33 |
Rapporto P/S | 0,99 |
Profilo aziendale
Die DocCheck AG bietet Marketing-, Customer Relationship Management- und E-Commerce-Dienstleistungen für den Gesundheitssektor in Europa an. Das Unternehmen betreibt das DocCheck-Portal für den Informationsaustausch im Internet sowie Online- und E-Commerce-Services für Akteure im Gesundheitsmarkt. Darüber hinaus entwickelt und implementiert es Kommunikationsstrategien für neue und traditionelle Medien im Gesundheitswesen und Business-to-Business-Sektor und fördert Startups im Gesundheitswesen durch Seed-Finanzierung. Die DocCheck AG hat ihren Sitz in Köln, Deutschland.
| Nome | DocCheck |
| CEO | Frank Nicolas Antwerpes |
| Sede centrale | Cologne,
nw Germania |
| Sito web | |
| Settore | Tecnologia dell'informazione |
| Industria | Servizi IT |
| Quotazione in borsa | 17/04/2020 |
| Dipendenti | 414 |
Simboli di borsa
| Borsa | Simbolo |
|---|---|
XETRA | AJ91.DE |
Frankfurt | AJ91.F |
Düsseldorf | AJ91.DU |
SIX | AJ91.SW |
München | AJ91.MU |
Scopri gli asset
Gli azionisti di DocCheck investono anche nei seguenti asset
